Close Menu

NEW YORK (GenomeWeb) – Scandinavian private equity firm Summa Equity said today that it has acquired Swedish life science firm Olink Proteomics.

According to the companies, Summa plans through the acquisition to help Olink scale its business globally. Based out of Uppsala, Sweden, Olink also maintains a US office and laboratory in Watertown, Massachusetts.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.